In detail, a recent review states that serial monitoring of N-terminal pro-B-type natriuretic peptide (NT-proBNP), cardiac troponins (cTn), soluble suppression of tumorigenesis-2 (sST2), and galectin-3 levels can help predict clinical outcomes in patients with heart failure. Here, NPPB is linked to heart failure.